CYTOSOLIX
Cytosolix develops novel oral and IV derivatives that target tumor acidity to improve the efficacy of small molecule cancer therapeutics. Cytosolix's Tumor Activated Permeability System, produces weakly-acidic derivatives of known oncology drugs, that enhance the uptake by cancer cells while restricting the uptake by healthy cells, enabling physicians to get safer and more effective therapy for drugs with dose-limiting toxicities.
CYTOSOLIX
Social Links:
Industry:
Biotechnology Health Care Medical
Founded:
2017-01-01
Address:
Tolland, Connecticut, United States
Country:
United States
Website Url:
http://www.cytosolix.com
Total Employee:
1+
Status:
Active
Total Funding:
230 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF WordPress Content Delivery Network Font Awesome Apache IPv6 Yoast WordPress SEO Plugin Google Apps For Business
Similar Organizations
BionPharma
BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.
Current Employees Featured
Founder
Investors List
Connecticut Innovations
Connecticut Innovations investment in Convertible Note - Cytosolix
Official Site Inspections
http://www.cytosolix.com
- Host name: 74-208-236-133.elastic-ssl.ui-r.com
- IP address: 74.208.236.133
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
